Kenya vs Senegal: Previously treated cases tested for RR-/MDR-TB
Kenya
87.0%
in 2024
Senegal
87.0%
in 2024
Kenya rank
92nd
Senegal rank
92nd
Previously treated cases tested for RR-/MDR-TB over time
- Kenya
- Senegal
How they compare
Kenya currently reports 87.0% against 87.0% in Senegal, a difference of 0.0%.
The two have swapped places 5 times across 18 shared years of data; in 2007 it was Kenya ahead.
Kenya ranks 92nd and Senegal ranks 92nd of 180 countries.
Across the 3 decades both report, Kenya averaged higher in 1 and Senegal in 2.
Head to head by decade
| Decade | Kenya | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.0% | 3.0% | 33.0% | Kenya |
| 2010s | 43.8% | 61.4% | 17.6% | Senegal |
| 2020s | 77.4% | 88.6% | 11.2% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Kenya or Senegal?
- Kenya, at 87.0% against 87.0% in Senegal as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Kenya and Senegal?
- 0.0%, with Kenya ahead.
- How many years of comparable data are there for Kenya and Senegal?
- 18 years are reported by both, from 2007 to 2024.
- How do Kenya and Senegal rank globally for previously treated cases tested for rr-/mdr-tb?
- Kenya ranks 92nd and Senegal ranks 92nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.